Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1560, 2006-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Raltegravir sets a new benchmark in triple-class resistant HIV-1
Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. :
Access to resources
Recommend
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :
Elvitegravir: a once-daily inhibitor of HIV-1 integrase
Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. :